Ibandronate in the treatment of postmenopausal osteoporosis: A cost-effectiveness analysis in the UK

被引：0
|
作者：
Earnshaw, S.
Lynch, N. O.
Cowell, W.
Beard, S.
机构：
[1] Roche Pharmaceut, London, England
[2] RTI Hlth Solut, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Ding, Y.
    Hay, J.
    VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [22] Economic analysis:: Ibandronate (Bonviva®) IV injection for the treatment of postmenopausal osteoporosis (PMO) in the UK
    Cowell, W.
    Koay, A.
    Hunjan, M.
    VALUE IN HEALTH, 2006, 9 (06) : A380 - A380
  • [23] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [24] Ibandronate sodium and zoledronate sodium in the treatment of senile osteoporosis: efficacy, impact on quality of life and cost-effectiveness analysis
    Liang, Shuang
    Hu, Shaozhen
    Guo, Hong
    Dong, Leilei
    Liu, Guoqiang
    Liu, Yang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (03): : 1764 - 1771
  • [25] Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK
    Fredrik Borgström
    Mattias Lorentzon
    Helena Johansson
    Nicholas C. Harvey
    Eugene McCloskey
    Damon Willems
    Douglas Knutsson
    John A. Kanis
    Osteoporosis International, 2024, 35 (12) : 2183 - 2193
  • [26] The cost-effectiveness of osteoporosis screening strategies for postmenopausal women
    Nayak, S.
    Greenspan, S. L.
    Liu, H.
    Michaud, K.
    Owens, D. K.
    Roberts, M. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 410 - 411
  • [27] Ibandronate is cost-effective in the treatment of postmenopausal osteoporosis: A comparision of bisphosphonates
    Lynch, N. O.
    Earnshaw, S. R.
    Beard, S.
    Cowell, W.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S11 - S11
  • [28] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Johnson, Ben
    Lai, Edward Chia-Cheng
    Ou, Huang-tz
    Li, Hong
    Stollenwerk, Bjorn
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [29] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Ben Johnson
    Edward Chia-Cheng Lai
    Huang-tz Ou
    Hong Li
    Björn Stollenwerk
    Archives of Osteoporosis, 2021, 16
  • [30] COST-EFFECTIVENESS ANALYSES OF SCREENING AND TREATMENT STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS IN CHINESE WOMEN
    Si, L.
    Winzenberg, T. M.
    Wang, L.
    Palmer, A. J.
    VALUE IN HEALTH, 2014, 17 (07) : A773 - A773
12345